Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2009
10/22/2009US20090264339 Heterocyclic Compounds
10/22/2009US20090263852 Nonapoptotic forms of cell death and methods of modulation
10/22/2009US20090263784 Three-dimensional structure of prostaglandin d synthase and utilization thereof
10/22/2009US20090263783 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
10/22/2009US20090263508 micronutrient supplement with calcium, vitamin d or calcium & vitamin d combination for premenstrual syndrome, postpartum depression, depression and panic attacks
10/22/2009US20090263492 Diagnostic Methods and Genetic Markers for Alzheimer Disease
10/22/2009US20090263481 Levetiracetam formulations
10/22/2009US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
10/22/2009US20090263466 Herbal composition for treatment of hyperlipidemia and the inhibition of myocardial infarction
10/22/2009US20090263461 Alpha adrenergic receptor agonists for treatment of degenerative disc disease
10/22/2009US20090263450 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
10/22/2009US20090263426 Methods for treating headache
10/22/2009US20090263374 Method of preventing and treating brain infarction
10/22/2009US20090263368 Genetic variations associated with psychiatric disorders
10/22/2009US20090263367 Composition and method for promoting internal health and external appearance
10/22/2009US20090263360 Neuronal progenitors from feeder-free human embryonic stem cell culture
10/22/2009US20090263346 Systems and methods for delivery of drugs
10/22/2009US20090263341 Soft anticholinergic esters
10/22/2009US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines
10/22/2009US20090263321 Compositions and Methods for Treating Post-Operative Pain Using Clonidine and Bupivacaine
10/22/2009CA2758829A1 Method of treating demyelinating disease
10/22/2009CA2725441A1 Indoles as modulators of nicotinic acetylcholin receptor subtype alpha-71
10/22/2009CA2721838A1 Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
10/22/2009CA2721837A1 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
10/22/2009CA2721670A1 3-phenylpyrazolo[5,1-b]thiazole compound
10/22/2009CA2721666A1 Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives
10/22/2009CA2721630A1 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7
10/22/2009CA2721568A1 An antibody bound synthetic vesicle containing active agent molecules
10/22/2009CA2721341A1 Ameliorating agent for neurogenic pain
10/22/2009CA2721339A1 Activating agent for peroxisome proliferator activated receptor
10/22/2009CA2721240A1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors
10/22/2009CA2721156A1 Stable amyloid beta monomers and oligomers
10/22/2009CA2721007A1 Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
10/22/2009CA2720670A1 Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use
10/22/2009CA2719789A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009CA2719785A1 Ether benzylidene piperidine aryl carboxamide compounds
10/22/2009CA2719784A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds
10/22/2009CA2717087A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamides
10/22/2009CA2714219A1 Kappa opioid receptor ligands
10/21/2009EP2110375A1 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
10/21/2009EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009EP2110141A1 Protective agent for retinal nerve or optic nerve
10/21/2009EP2110139A2 Method for identifying an anti-myelin associated glycoprotein (MAG) antibody
10/21/2009EP2110135A2 A pharmaceutical composition for treating depression and method for preparation thereof
10/21/2009EP2110129A1 Use of enantiomer (1S, 2R) milnacipran hydrochloride for the preventive treatment of suicidal behaviour in depressed patients
10/21/2009EP2110028A1 Bifidobacterium longum and hippocampal BDNF expression
10/21/2009EP2109615A1 Substituted pyrano [2, 3 - b]pyridine derivatives as cannabinoid-1 receptor modulators
10/21/2009EP2109613A2 Polymorphs of eszopiclone malate
10/21/2009EP2109610A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
10/21/2009EP2109604A1 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives
10/21/2009EP2109600A2 Amorphous and crystalline forms of rivastigmine hydrogentartrate
10/21/2009EP2109465A2 Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same
10/21/2009EP2040703B1 Derivatives of 2-benzoyl-imidazopyridines, preparation method thereof and use of same in therapeutics
10/21/2009EP1979320B1 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/21/2009EP1838318B1 Use of oxycodone for treating visceral pain
10/21/2009EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/21/2009EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof
10/21/2009EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
10/21/2009EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
10/21/2009EP1423413B1 Peptidic compounds selectively binding to p-selectin
10/21/2009EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors
10/21/2009EP1292680B1 Agonist anti-trk-c monoclonal antibodies
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009EP1164991B1 Gels formed by the interaction of poly(aldehyde) with various substances
10/21/2009EP1047436B1 N-acetylhomotaurinates for use in treating hyperkinesias
10/21/2009EP0900200B9 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
10/21/2009CN101563350A Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl]-phenyl-N-methyl-acetamide
10/21/2009CN101563344A Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/21/2009CN101563343A Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/21/2009CN101563336A Heterocyclic organic compounds for the treatment of in particular melanoma
10/21/2009CN101563332A Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments
10/21/2009CN101563328A Substituted heteroaryl pyridopyrimidone derivatives
10/21/2009CN101563323A Spiro-piperidine derivatives
10/21/2009CN101563321A 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands
10/21/2009CN101563320A [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
10/21/2009CN101563318A N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
10/21/2009CN101563106A Combination of nmda- receptor ligand and a compound with 5-HT6 receptor affinity
10/21/2009CN101563083A Combinations containing a 4-acylaminopyridine derivative
10/21/2009CN101563080A Ligustilide derivatives for the treatment of disorders of the central nervous system
10/21/2009CN101563079A Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
10/21/2009CN101563075A Therapeutic agent for diabetic neuropathy
10/21/2009CN101563071A Oral transmucosal nicotine dosage form
10/21/2009CN101560718A Method for preparing functional nano fibrous membrane by multi-component consolute single-step method
10/21/2009CN101560529A Arachidonic acid and methods for the production and use thereof
10/21/2009CN101560230A Helicid extraction method
10/21/2009CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
10/21/2009CN101560207A Preparation method of paroxetine hydrochloride and intermediate thereof
10/21/2009CN101560199A Preparation method of Escitalopram
10/21/2009CN101560179A Azotic indole derivative with H3 receptor affinity and applications
10/21/2009CN101559274A Health care running machine and method for processing felt thereon
10/21/2009CN101559201A Traditional Chinese medicine for treating epilepsy
10/21/2009CN101559195A Epilepsy therapy capsule and preparation method thereof
10/21/2009CN101559175A Compound decoction of divaricate saposhnikovia root and eucommia bark for treating headache
10/21/2009CN101559168A Pharmaceutical composition for invigorating Qi, tonifying blood and nourishing liver and kidney as well as preparation method and application thereof
10/21/2009CN101559165A Shengcao kidney-tonifying oral liquid
10/21/2009CN101559161A Application of traditional Chinese medicine composition in preparing medicament for curing tristimania
10/21/2009CN101559156A Application of traditional Chinese medicine composition in preparing medicament for curing chronic inflammatory demyelinating polyneuropathy
10/21/2009CN101559152A Chinese materia medica preparation for treating hydrocephalus and preparation method thereof
10/21/2009CN101559139A Prescription of pure traditional Chinese medicine preparation for preventing and curing neurasthenia insomnia and preparation method thereof
1 ... 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 ... 1833